In conclusion, we report on the identification of hepatic PLZF as a novel candidate gene for NAFLD via binding to the promoter of SREBP-1c and upregulating lipogenic genes. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.